Diabetes Mellitus Reversal Via Implantation of Magnetically Purified Microencapsulated Pseudoislets
- Authors:
- A. Espona-Noguera, J. Etxeberria-Elezgarai, L. Saenz del Burgo, A. Cañibano-Hernández, H. Gurruchaga, F. J. Blanco, G. Orive, R. M. Hernández, F. Benito-Lopez; J. Ciriza, L. Basabe-Desmonts*, J. Luis Pedraz*
- Year:
- 2019
- Journal:
- Int. P. Pharm. (IF: 3.862, 2017, Q1)
- Volume:
- 560
- Initial page - Ending page:
- 65 - 77
- ISBN/ISSN:
- 0378-5173
- Description:
-
Microencapsulation of pancreatic islets for the treatment of Type I Diabetes Mellitus (T1DM) generates a high
quantity of empty microcapsules, resulting in high therapeutic graft volumes that can enhance the host
’
s immune
response. We report a 3D printed micro
fl
uidic magnetic sorting device for microcapsules puri
fi
cation with the
objective to reduce the number of empty microcapsules prior transplantation. In this study, INS1E pseudoislets
were microencapsulated within alginate (A) and alginate-poly-L-lysine-alginate (APA) microcapsules and pur-
i
fi
ed through the micro
fl
uidic device. APA microcapsules demonstrated higher mechanical integrity and stability
than A microcapsules, showing better pseudoislets viability and biological function. Importantly, we obtained a
reduction of the graft volume of 77.5% for A microcapsules and 78.6% for APA microcapsules. After sub-
cutaneous implantation of induced diabetic Wistar rats with magnetically puri
fi
ed APA microencapsulated
pseudoislets, blood glucose levels were restored into normoglycemia (< 200 mg/dL) for almost 17 weeks. In
conclusion, our described micro
fl
uidic magnetic sorting device represents a great alternative approach for the
graft volume reduction of microencapsulated pseudoislets and its application in T1DM disease.